Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
1.400
-0.130 (-8.50%)
At close: Feb 21, 2025, 4:00 PM
1.410
+0.010 (0.71%)
After-hours: Feb 21, 2025, 7:40 PM EST
Gossamer Bio Employees
Gossamer Bio had 135 employees as of December 31, 2023. The number of employees decreased by 43 or -24.16% compared to the previous year.
Employees
135
Change (1Y)
-43
Growth (1Y)
-24.16%
Revenue / Employee
$780,163
Profits / Employee
-$530,719
Market Cap
317.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
GOSS News
- 8 days ago - Gossamer Bio Is A Good Speculative Buy On Seralutinib For PAH And PH-ILD - Seeking Alpha
- 14 days ago - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 19 days ago - Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
- 25 days ago - Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
- 3 months ago - Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 5 months ago - Gossamer Bio Has One More Shot On Goal And Is Not Likely To Miss - Seeking Alpha
- 6 months ago - Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024 - Business Wire
- 6 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire